| 000 | 01787 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514010221.0 | ||
| 264 | 0 | _c20010927 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0012-3706 | ||
| 024 | 7 |
_a10.1007/BF02234627 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuldenschuh, I | |
| 245 | 0 | 0 |
_aRelationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. _h[electronic resource] |
| 260 |
_bDiseases of the colon and rectum _cAug 2001 |
||
| 300 |
_a1090-7; discussion 1097-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenomatous Polyposis Coli _xdrug therapy |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aColonoscopy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, APC _xgenetics |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGerm-Line Mutation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSulindac _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHurlimann, R | |
| 700 | 1 | _aMuller, A | |
| 700 | 1 | _aAmmann, R | |
| 700 | 1 | _aMullhaupt, B | |
| 700 | 1 | _aDobbie, Z | |
| 700 | 1 | _aZala, G F | |
| 700 | 1 | _aFlury, R | |
| 700 | 1 | _aSeelentag, W | |
| 700 | 1 | _aRoth, J | |
| 700 | 1 | _aMeyenberger, C | |
| 700 | 1 | _aFried, M | |
| 700 | 1 | _aHoppeler, T | |
| 700 | 1 | _aSpigelman, A D | |
| 700 | 1 | _aScott, R J | |
| 773 | 0 |
_tDiseases of the colon and rectum _gvol. 44 _gno. 8 _gp. 1090-7; discussion 1097-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02234627 _zAvailable from publisher's website |
| 999 |
_c11459539 _d11459539 |
||